Podium to Practice: EHA 2026 – Lymphoma: CLL14 Final Analysis
OR
Studies / Trials Discussed
S146 – VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: FINAL RESULTS OF THE RANDOMIZED CLL14 STUDY
Co-Chairs
Speakers
Explore more from your favourite experts – click their name to access their entire library of content.
This program has been made possible through unrestricted support from Merck.
Studies/trials discussed:
S146 – VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: FINAL RESULTS OF THE RANDOMIZED CLL14 STUDY
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.